Effects of wave reflection timing on left ventricular mechanics.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 10093024)

Published in J Biomech on March 01, 1999

Authors

R Zannoli1, P Schiereck, F Celletti, A Branzi, B Magnani

Author Affiliations

1: Institute of Cardiovascular Diseases, University of Bologna, Italy.

Articles citing this

The cardiac blood supply-workload balance in children. Heart Vessels (2014) 0.75

Articles by these authors

Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation: a 10-year experience. Chest (2001) 5.12

The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. The Survival of Myocardial Infarction Long-Term Evaluation (SMILE) Study Investigators. N Engl J Med (1995) 4.61

Absence of photosystem 2 in heterocysts of the blue-green alga Anabaena. Biochim Biophys Acta (1972) 2.09

Randomised comparison of subcutaneous heparin, intravenous heparin, and aspirin in unstable angina. Studio Epoorine Sottocutanea nell'Angina Instobile (SESAIR) Refrattorie Group. Lancet (1995) 2.05

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol (1992) 1.66

Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and nonsustained ventricular tachycardia. Circulation (1994) 1.61

Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart (2005) 1.57

Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis. Bone Marrow Transplant (2005) 1.55

Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction. Heart (2006) 1.53

Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens (1998) 1.46

Malignant vasovagal syncope: a randomised trial of metoprolol and clonidine. Heart (1997) 1.42

Coronary stenting with the half (disarticulated) Palmaz-Schatz stent: immediate results and six-month follow-up. Cathet Cardiovasc Diagn (1997) 1.40

[Diagnostic contribution of magnetic resonance in clinically suspected arrhythmogenic dysplasia of the right ventricle]. G Ital Cardiol (1996) 1.39

Warm-up, stretching and massage diminish harmful effects of eccentric exercise. Int J Sports Med (1994) 1.24

Nightmares and sleep disturbances with simvastatin and metoprolol. Ann Pharmacother (2001) 1.12

Evidence of a partial escape of renin-angiotensin-aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol (1993) 1.10

A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol (1994) 1.09

Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators. J Hypertens (1997) 1.09

A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial. Eur Heart J (1999) 1.07

The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J Hypertens (1998) 1.06

A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy. Am J Hum Genet (1998) 1.06

Opposite effects of interleukin 10 common gene polymorphisms in cardiovascular diseases and in successful ageing: genetic background of male centenarians is protective against coronary heart disease. J Med Genet (2004) 1.04

Pulmonary arterial hypertension associated to connective tissue diseases. Lupus (2005) 1.03

Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial). J Am Coll Cardiol (1994) 1.00

N-acetylcysteine reduces methemoglobin in vitro. Ann Emerg Med (1996) 1.00

Dynamic electrophysiological behavior of human atria during paroxysmal atrial fibrillation. Circulation (1995) 0.99

Benefits in projected pacemaker longevity and in pacing related costs conferred by automatic threshold tracking. Pacing Clin Electrophysiol (2000) 0.99

Evaluation of the pulse-contour method of determining stroke volume in man. Circulation (1972) 0.98

Atrial premature beats coupling interval determines lone paroxysmal atrial fibrillation onset. Int J Cardiol (1992) 0.97

Transvenous low energy internal cardioversion for atrial fibrillation: a review of clinical applications and future developments. Pacing Clin Electrophysiol (2001) 0.96

Caffeine suppresses length dependency of Ca2+ sensitivity of skinned striated muscle. Am J Physiol (1988) 0.96

Effects of the administration of an angiotensin-converting enzyme inhibitor during the acute phase of myocardial infarction in patients with arterial hypertension. SMILE Study Investigators. Survival of Myocardial Infarction Long-term Evaluation. Am J Hypertens (1999) 0.95

Oral propafenone to convert recent-onset atrial fibrillation in patients with and without underlying heart disease. A randomized, controlled trial. Ann Intern Med (1997) 0.94

Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality. Heart (2008) 0.93

Role of pharmacologic tests in the treatment of primary pulmonary hypertension. Am J Cardiol (1995) 0.92

Clinical value of multidetector CT coronary angiography as a preoperative screening test before non-coronary cardiac surgery. Heart (2006) 0.92

Atherosclerosis and calcium antagonists: the VHAS. The Verapamil-Hypertension Atherosclerosis Study (VHAS) Investigators. J Hum Hypertens (1992) 0.92

Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J (1998) 0.91

Increased intralymphocytic sodium content in essential hypertension: an index of impaired Na+ cellular metabolism. Clin Sci (Lond) (1981) 0.91

Magnetic resonance imaging evaluation of aortic elastic properties as early expression of Marfan syndrome. J Cardiovasc Magn Reson (2000) 0.91

Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol (1998) 0.91

A fluorescence depolarization study of the orientational distribution of crossbridges in muscle fibres. Eur Biophys J (1994) 0.90

Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial. Postgrad Med J (1986) 0.90

Enhanced thrombolytic efficacy and reduction of infarct size by simultaneous infusion of streptokinase and heparin. Br Heart J (1990) 0.90

[Paroxysmal atrial fibrillation: study of the pattern of onset using dynamic electrocardiography]. Cardiologia (1989) 0.89

Medical therapy of pulmonary hypertension. The prostacyclins. Clin Chest Med (2001) 0.88

Platelet and neutrophil activation during cardiac surgical procedures: impact of cardiopulmonary bypass. Ann Thorac Surg (1998) 0.87

Effects of a low-salt diet and of acute salt loading on blood pressure and intralymphocytic sodium concentration in young subjects with borderline hypertension. Clin Sci (Lond) (1981) 0.87

Effects of moderate salt restriction on intralymphocytic sodium and pressor response to stress in borderline hypertension. Hypertension (1983) 0.87

On the mechanism by which saxitoxin binds to and blocks sodium channels. Ann N Y Acad Sci (1986) 0.86

Delayed surgery of traumatic aortic rupture. Role of magnetic resonance imaging. Circulation (1996) 0.86

Autocrine and intracrine signaling for cardiogenesis in embryonic stem cells: a clue for the development of novel differentiating agents. Handb Exp Pharmacol (2006) 0.85

On the value of the activated clotting time for monitoring heparin therapy in acute coronary syndromes. Am J Cardiol (1993) 0.85

Primary pulmonary hypertension: insights into pathogenesis from epidemiology. Chest (1998) 0.85

Interplay between methylenetetrahydrofolate reductase gene polymorphism 677C-->T and serum folate levels in determining hyperhomocysteinemia in heart transplant recipients. J Heart Lung Transplant (2001) 0.85

Idiopathic restrictive cardiomyopathy in the young: report of two cases. Int J Cardiol (1990) 0.85

Evaluation by cardiopulmonary exercise test of DDDR versus DDD pacing. Pacing Clin Electrophysiol (1992) 0.84

Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin's disease patients. Haematologica (1996) 0.84

Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party. Am Heart J (1998) 0.84

Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men. Int J Immunogenet (2005) 0.84

An electromyographic study of the vastii muscles during open and closed kinetic chain submaximal isometric exercises. Int J Sports Phys Ther (2012) 0.84

Efficacy and tolerability in fully conscious patients of transvenous low-energy internal atrial cardioversion for atrial fibrillation. Am J Cardiol (1998) 0.84

Snoring every night as a risk factor for myocardial infarction: a case-control study. BMJ (1990) 0.84

Psychological evaluation after cardiac transplantation: the integration of different criteria. Psychother Psychosom (2001) 0.83

Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters. Heart (2002) 0.83

[Tetralogy of Fallot associated with total anomalous pulmonary venous drainage. Case report (author's transl)]. G Ital Cardiol (1980) 0.83

Low energy internal atrial cardioversion in atrial fibrillation lasting more than a year. Pacing Clin Electrophysiol (1999) 0.83

Propafenone for conversion of recent-onset atrial fibrillation. A controlled comparison between oral loading dose and intravenous administration. Chest (1995) 0.83

[Visceral and ocular Larva migrans: epidemiologic study, clinical and immunologic findings on 20 cases, adult and child]. Bull Soc Pathol Exot Filiales (1989) 0.83

Doxorubicin interacts directly with skinned single skeletal muscle fibres. Eur J Pharmacol (1992) 0.83

The potencies of synthetic analogues of saxitoxin and the absolute stereoselectivity of decarbamoyl saxitoxin. Toxicon (1995) 0.82

N-acetylcysteine reduces methemoglobin in an in-vitro model of glucose-6-phosphate dehydrogenase deficiency. Acad Emerg Med (1998) 0.82

The new clinical trials on pharmacological treatment in pulmonary arterial hypertension. Eur Respir J (2002) 0.82

Intralymphocytic sodium concentration: a sensitive index to identify young subjects at risk of hypertension. Clin Exp Hypertens (1981) 0.82

Relaxation time constant of isolated rabbit left ventricle. Am J Physiol (1987) 0.82

Genetic heterogeneity of hypertrophic cardiomyopathy. Int J Cardiol (1985) 0.82

Vagal efferent control of electrical properties of the heart in experimental diabetes. Acta Diabetol (1998) 0.82

Electrophysiological effects of flecainide and propafenone on atrial fibrillation cycle and relation with arrhythmia termination. Heart (1999) 0.82

Favorable effects of flecainide in transvenous internal cardioversion of atrial fibrillation. J Am Coll Cardiol (1999) 0.82

Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Int J Clin Pract (2007) 0.81

Reduced oxidative activity of circulating neutrophils in patients after myocardial infarction. Cell Biochem Funct (1990) 0.81

Results of coronary stenting for unstable versus stable angina pectoris. Am J Cardiol (1997) 0.81

Renal haemodynamics after chronic treatment with labetalol and propranolol. Br J Clin Pharmacol (1982) 0.81

Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects. Am J Cardiol (1993) 0.81

Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. Am J Transplant (2013) 0.81